MedTrace Logo

Efficacy of Bilateral Modified Catheter Antegrade Cerebral Perfusion in Acute Type A Aortic Dissection Surgery

NCT06943716 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 273

Last updated 2025-05-07

No results posted yet for this study

Summary

This retrospective cohort study aims to evaluate the efficacy of a Bilateral Modified Catheter Antegrade Cerebral Perfusion (Modified bACP) technique in acute Type A aortic dissection surgery. Medical records from January 1, 2021, through October 31, 2024, at China Medical University Hospital will be reviewed. The primary outcomes include in-hospital mortality and stroke rate, while secondary outcomes include ICU/hospital stay, mechanical ventilation duration, and other postoperative complications (e.g., acute kidney injury, sepsis, myocardial infarction).

Conditions

  • Acute Type A Aortic Dissection

Interventions

PROCEDURE

Modified Catheter Antegrade Cerebral Perfusion (Modified bACP)

A modified bilateral catheter antegrade cerebral perfusion technique used for acute Type A aortic dissection repair. This approach aims to reduce surgical trauma by avoiding additional right axillary access while maintaining stable cerebral perfusion.

PROCEDURE

Conventional Brain Perfusion

Patients receiving the conventional perfusion strategy for aortic arch surgery, which may include standard bilateral ACP based on the surgeon's preference and the patient's condition.

Sponsors & Collaborators

  • China Medical University Hospital

    lead OTHER

Principal Investigators

  • En-Bo Wu, M.D. · Department of Anesthesiology, China Medical University Hospital, China Medical University, Taichung City 404, Taiwan

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-01
Primary Completion
2024-10-31
Completion
2025-04-11

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06943716 on ClinicalTrials.gov